Healthcare  Name:  Sector:  Chief Executive: Dendreon Healthcare Mitchell H. Gold, M.D.  Summary: Developing cell-based therapies for the treatment of cancer and chronic infectious disease.  Stage of Initial  Investment: Venture  Liquidity: IPO (NASDAQ: DNDN) 3005 First Avenue Seattle, WA 98121 Phone: 206.256.4545 Fax: 206.256.0571
	Copyright ©2007 Rho Capital Partners, Inc.